Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myo-Inositol in PCOS Women Undergoing ART
NCT03177122Phase 4Unknown
- Sponsor
- American University of Beirut Medical Center
- Start
- Mar 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of myo-inositol in polycystic ovary syndrome (PCOS), sponsored by American University of Beirut Medical Center. Primary endpoints: Oocyte yield and Maturation rate. Status: unknown.
02
Drugs
myo-inositol
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03177122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03177122.